We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$37.7B
AUM Growth
-$827M
Cap. Flow
-$2.24B
Cap. Flow %
-5.96%
Top 10 Hldgs %
34.71%
Holding
99
New
21
Increased
17
Reduced
29
Closed
23

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$988M
2
JPM icon
JPMorgan Chase
JPM
+$976M
3
BLK icon
Blackrock
BLK
+$722M
4
PM icon
Philip Morris
PM
+$718M
5
META icon
Meta Platforms (Facebook)
META
+$682M

Sector Composition

Rank Sector Weight
1 Financials 23.65%
2 Consumer Discretionary 19.94%
3 Technology 15.37%
4 Healthcare 13.34%
5 Industrials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
51
Arthur J. Gallagher & Co
AJG
$65B
$269M 0.72%
+1,040,977
New +$276M
BAC icon
52
Bank of America
BAC
$448B
$247M 0.66%
4,494,629
-7,005,661
-61% -$370M
BSX icon
53
Boston Scientific
BSX
$74.2B
$239M 0.64%
2,509,808
-131,874
-5% -$12.9M
DLR icon
54
Digital Realty Trust
DLR
$70.6B
$233M 0.62%
+1,507,988
New +$248M
LOW icon
55
Lowe's Companies
LOW
$124B
$220M 0.58%
+912,040
New +$219M
FIG
56
Figma
FIG
$13.3B
$215M 0.57%
+5,752,388
New +$260M
ITUB icon
57
Itaú Unibanco
ITUB
$82.7B
$203M 0.54%
+28,396,545
New +$202M
AS icon
58
Amer Sports
AS
$19.7B
$180M 0.48%
4,814,290
-1,529,191
-24% -$52.5M
RAL
59
Ralliant Corp
RAL
$7.91B
$161M 0.43%
3,162,630
-1,919,842
-38% -$90M
RIOT icon
60
Riot Platforms
RIOT
$7.6B
$157M 0.42%
+12,428,894
New +$213M
NAMS icon
61
NewAmsterdam Pharma
NAMS
$3.3B
$147M 0.39%
4,203,567
-2,271,967
-35% -$82.7M
ROIV icon
62
Roivant Sciences
ROIV
$25.5B
$140M 0.37%
6,443,191
-17,151,640
-73% -$338M
IQV icon
63
IQVIA
IQV
$40.1B
$140M 0.37%
+619,236
New +$135M
SION
64
Sionna Therapeutics
SION
$231M
$131M 0.35%
3,195,181
INBX icon
65
Inhibrx
INBX
$1.36B
$114M 0.3%
1,437,705
-350,000
-20% -$23.8M
PHVS icon
66
Pharvaris
PHVS
$2.41B
$101M 0.27%
3,653,310
CSGP icon
67
CoStar Group
CSGP
$12.6B
$97M 0.26%
1,442,582
-407,147
-22% -$28.8M
WST icon
68
West Pharmaceutical
WST
$24.7B
$81.2M 0.22%
+295,028
New +$80.7M
ORKA
69
Oruka Therapeutics
ORKA
$6.93B
$80.8M 0.21%
2,666,690
LAB icon
70
Standard BioTools
LAB
$309M
$75.1M 0.2%
58,651,170
MASI
71
DELISTED
Masimo
MASI
$66.9M 0.18%
514,340
-559,093
-52% -$80.1M
ORIC icon
72
Oric Pharmaceuticals
ORIC
$1.42B
$53.8M 0.14%
6,572,691
-9
-0% -$104
TRVI icon
73
Trevi Therapeutics
TRVI
$2.54B
$40M 0.11%
3,198,644
-1,930,231
-38% -$22.3M
DNA icon
74
Ginkgo Bioworks
DNA
$506M
$29.7M 0.08%
3,577,128
PEPG icon
75
PepGen
PEPG
$201M
$22.7M 0.06%
3,482,434

Similar funds

Viking Global Investors's Q4 2025 Portfolio in Review

As of Q4 2025, Viking Global Investors held 99 positions worth $37.7B, down 2.1% from $38.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Viking Global Investors withdrew a net $2.24B in Q4 2025, closing 23 positions and reducing 29 holdings. Its most notable exit was Blackrock, an estimated $722M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Viking Global Investors opened a new position in Alphabet (Google) Class A worth $835M.

  • Viking Global Investors's largest Q4 2025 buy was Alphabet (Google) Class A: 2,666,272 shares worth $835M.
  • Viking Global Investors added most to Microsoft in Q4 2025, an estimated $395M increase.
  • Viking Global Investors's biggest Q4 2025 reduction was Capital One, cutting an estimated $988M.
  • Viking Global Investors fully exited Blackrock in Q4 2025, selling an estimated $722M.
  • Viking Global Investors's ten largest holdings make up 35% of its $37.7B portfolio in Q4 2025.
  • Viking Global Investors opened 21 new positions and closed 23 in Q4 2025.
  • Viking Global Investors's portfolio value fell 2.1% quarter-over-quarter to $37.7B.

Based on Viking Global Investors's 13F filing for Q4 2025, filed 17 Feb 2026.